Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 24, 2008 02:00 ET | Source: Summit Therapeutics plc

CO-DEVELOPMENT DEAL

Summit Corporation plc ("Summit plc" or "the Company") SUMMIT SIGNS A CO-DEVELOPMENT AGREEMENT WITH ORIENT PHARMA TO ADVANCE CLINICAL DEVELOPMENT OF SIALORRHOEA PROGRAMME Oxford,...
August 22, 2008 02:00 ET | Source: Summit Therapeutics plc

Directorate change

Oxford, UK, 22 August 2008 - Summit Corporation plc (AIM: SUMM), a leading UK biotechnology company, announces that the Company's Chief Financial Officer, Darren Millington, has decided to leave the...
July 22, 2008 11:10 ET | Source: Summit Therapeutics plc

Issue of Equity: Application to AIM

Summit Corporation plc ("Summit plc" or "the Company") APPLICATION FOR ADMISSION OF NEW ORDINARY SHARES Oxford, UK, 22 July 2008 - Summit Corporation plc (AIM: SUMM), a UK...
July 22, 2008 02:00 ET | Source: Summit Therapeutics plc

Re Agreement with BioMarin to develop DMD candidate

A conference call for analysts, investors and press will take place at 09.30hrs (BST) and the presentation is available by contacting investors@summitplc.com or...
July 09, 2008 05:36 ET | Source: Summit Therapeutics plc

AGM Statement

Summit Corporation plc ("Summit plc" or "the Company") RESULTS OF ANNUAL GENERAL...
June 03, 2008 02:00 ET | Source: Summit Therapeutics plc

Final Results

Summit Corporation plc ("Summit plc" or "the Company") PRELIMINARY RESULTS FOR THE YEAR ENDED 31 JANUARY 2008 Oxford, UK, 3 June 2008 - Summit Corporation plc (AIM: SUMM), a leading...
May 01, 2008 04:00 ET | Source: Summit Therapeutics plc

Notice of Preliminary Results for Year ended 31 January 2008

Summit Corporation plc ("Summit plc" or "the Company") NOTICE OF PRELIMINARY RESULTS Oxford, UK, 1 May 2008 - Summit Corporation plc (AIM: SUMM), a leading UK biotechnology company,...
April 29, 2008 02:00 ET | Source: Summit Therapeutics plc

Research Update - New Positive Data from DMD Programme

Summit Corporation plc ("Summit plc" or "the Company") SUMMIT REPORTS PROGRESS OF DUCHENNE MUSCULAR DYSTROPHY PROGRAMME AT INTERNATIONAL CONFERENCE Drug candidate SMT C1100...
April 15, 2008 02:00 ET | Source: Summit Therapeutics plc

Positive results from Phase I clinical trial in acne

Summit Corporation plc ("Summit plc" or "the Company") POSITIVE RESULTS FROM PHASE I CLINICAL TRIAL OF SMT D002 FOR THE TREATMENT OF SEBORRHOEA, A PRIMARY CAUSE OF ACNE SMT D002...
April 09, 2008 04:30 ET | Source: Summit Therapeutics plc

Zebrafish Data Presented at International Conferences

Summit Corporation plc ("Summit" or "the Company") SUMMIT PRESENTS THE BENEFITS ZEBRAFISH BRING TO DRUG DISCOVERY AND DEVELOPMENT AT TWO INTERNATIONAL CONFERENCES Oxford, UK, 9...